3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
21
NETWORK
5
INDUSTRY
2
OTHER_GOV
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Small Cell Lung Carcinoma
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Hodgkin Disease
1
Interventions
spartalizumab
1
apatinib
1
Zoledronic Acid
1
Nivolumab
1
Ipilimumab
1
Ifosfamide
1
Doxorubicin
1
Ashwagandha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Osteosarcoma
×
Ifosfamide
×
Clear all
NCT00691236
2011-06-23
ZOL
Tata Memorial Hospital
Phase 2/3
Unknown
60 enrolled